[Nicotinic acid and the derivative].
Ogaki
S
S
Department of Internal Medicine, Tsukuba Memorial Hospital.
Matsushima
T
T
D000924:Anticholesteremic Agents / Q000627:therapeutic use; D002986:Clinical Trials as Topic; D003327:Coronary Disease / Q000209:etiology / Q000517:prevention & control; D004359:Drug Therapy, Combination; D006801:Humans; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors / Q000627:therapeutic use; D006949:Hyperlipidemias / Q000097:blood / Q000188:drug therapy; D000960:Hypolipidemic Agents / Q000627:therapeutic use; D008055:Lipids / Q000097:blood; D009525:Niacin / Q000009:adverse effects / Q000031:analogs & derivatives* / Q000627:therapeutic use*; D011341:Probucol
D000924:Anticholesteremic Agents; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors; D000960:Hypolipidemic Agents; D008055:Lipids; D009525:Niacin; D011341:Probucol